QQ客服 官方微博 反馈留言

	Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation
	Liu,H.; Liu,X.; Wei,X.; Chen,L.; Xiang,Y.; Yi,F.; Zhang,X.
刊名	Brain research bulletin
	2012
期号	1页码:65-70
关键词	Angiotensin II type 1 receptor Cerebral ischemia-reperfusion injury Losartan Phosphorylated eNOS PI3K/Akt signaling
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5199514
专题	山东大学
作者单位	1.Department of Pharmacology, Shandong University, School of Medicine, Jinan, Shandong 250012, China 2.Department of Pharmacology, S
推荐引用方式 GB/T 7714	Liu,H.,Liu,X.,Wei,X.,et al. Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation[J]. Brain research bulletin,2012(1):65-70.
APA	Liu,H..,Liu,X..,Wei,X..,Chen,L..,Xiang,Y..,...&Zhang,X..(2012).Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation.Brain research bulletin(1),65-70.
MLA	Liu,H.,et al."Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation".Brain research bulletin .1(2012):65-70.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。